熱門資訊> 正文
Veea和NovaGen计划7.5亿美元的业务合并
2026-09-15 04:57
- Veea (VEEA) and NovaGen Group signed a term sheet to combine, targeting a definitive business combination agreement within the coming weeks.
- The companies will launch NovaGen Health Networks, combining Veea’s edge computing, connectivity and cybersecurity with NovaGen’s regenerative medicine platform, with initial deployments planned for Q4 2026.
- GeoNova Capital has committed to invest $10M in the combined company as a cornerstone investor.
- Management estimates the combined company could be valued at ~$750M, based on internal projections and an independent valuation.
- The platform will initially connect health records, wearable data and biological measurements, with plans to expand into clinician-supervised diagnostics and therapy pathways subject to clinical validation and regulatory approvals.
More on Veea Inc.
- Financial information for Veea Inc.
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。